BIDDEFORD — Biddeford emergency medical services transported a woman to the hospital late Wednesday night after she reportedly had a drug overdose.
EMS arrived at an apartment on Sullivan Street about 11 p.m. and transported Hannah Courtois, 23, to Southern Maine Health Care in Biddeford, police said on Friday. Courtois was administered Narcan by an unknown person before emergency personnel arrived, according to police.
Biddeford Police Chief Roger Beaupre could not confirm what drug led to the overdose. However, he said he could “reasonably say it was an opiate” due to Courtois’ positive reaction to the Narcan, or naloxone, a medication that reverses the effects of opioids and is often used in overdose cases.
Courtois was out on bail for a previous arrest for operating under the influence and crashing into the Paquin & Carroll building on Main Street on Jan. 29, according to Deputy Chief JoAnne Fisk.
She was interviewed by police at the hospital and issued a summons for violation of conditions of release, which include the stipulation that she not use or possess illegal drugs.
“We are trying to encourage her to seek treatment,” Beaupre said Friday. “We try to encourage treatment with all these overdose cases. We always have.”
— Staff Writer Alan Bennett can be contacted at 282-1535, ext. 329 or abennett@journaltribune.com.
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less